Business Segments Apollo Global Management, Inc.
Equities
APO
US03769M1062
Investment Management & Fund Operators
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
172.06 USD | +1.36% | +3.04% | +4.18% |
Jan. 23 | JPMorgan Raises Apollo Global Management's Price Target to $178 From $161 | MT |
Jan. 23 | Guidewire Software to Join S&P MidCap 400, Arrowhead Pharmaceuticals to Move to S&P SmallCap 600 | MT |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
EBT: Breakdown by Business Segment
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Investment Funds | ||||||||||
Retirement Services | - | - | - | 6.96B | 9.68B | |||||
Total Assets | - | - | - | 246B | 295B | |||||
EBT | - | - | - | - | 3.24B | |||||
Asset Management | - | - | - | 2.62B | 3.16B | |||||
Total Assets | - | - | - | 13.4B | 1.94B | |||||
Interest Expense | - | - | - | -124M | -145M | |||||
EBT | - | - | - | - | 2.26B | |||||
Principal Investing | - | - | - | 925M | 740M | |||||
Total Assets | - | - | - | - | 9.57B | |||||
EBT | - | - | - | - | 83M | |||||
Real Estate - Management | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Credit - Management | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Private Equity - Management | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Private Equity - Incentive | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Credit - Incentive | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Real Estate - Incentive | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Real Assets | 196M | 216M | 284M | - | - | |||||
Total Assets | 907M | 726M | 872M | - | - | |||||
EBT | 64.76M | 58.09M | 105M | - | - | |||||
Credit | 844M | 1.06B | 1.34B | - | - | |||||
Total Assets | 3.13B | 4.71B | 7.63B | - | - | |||||
EBT | 579M | 668M | 1.18B | - | - | |||||
Investment Company and Business Development Companies | ||||||||||
Private Equity | 595M | 631M | 611M | - | - | |||||
Total Assets | 3.3B | 3.24B | 5.07B | - | - | |||||
EBT | 571M | 294M | 959M | - | - | |||||
Unallocated Principal Investment Income | 170M | 89.04M | 672M | - | - | |||||
EBT | 136M | -420M | 2.43B | - | - | |||||
EBT | 88.58M | 62.48M | 222M | - | - | |||||
EBT | -70.96M | -67.85M | -79.78M | - | - | |||||
EBT | -96.21M | -129M | -146M | - | - | |||||
EBT | -208M | -33.35M | -649M | - | - | |||||
EBT | 435M | 34.8M | 1.46B | - | - | |||||
EBT | -21.99M | -3.89M | - | - | - | |||||
EBT | - | - | -66.85M | - | - | |||||
EBT | - | - | -949M | - | - | |||||
Unallocated Performance Fees | 1.04B | 316M | 3.05B | - | - | |||||
Unallocated Other | - | - | - | - | - | |||||
Total Assets | 1.2B | 14.99B | 16.93B | - | 7.25B | |||||
EBT | 30.5M | 118M | 418M | - | - | |||||
EBT | -49.21M | -39.19M | -34.59M | - | - | |||||
EBT | -50.31M | 12.43M | 9.61M | - | - | |||||
Unallocated Adjustments Related to Consolidated Funds and Vies | -12.85M | -78.3M | -146M | - | - | |||||
Unallocated Equity Awards Granted by Unconsolidated Related Parties, Reimbursable Expenses and Other | 103M | 118M | 138M | - | - | |||||
Corporate and Other | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
EBT | - | - | - | - | - |
Geographical Revenue Distribution History
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
United States | 2.83B | 2.22B | 5.81B | 10.84B | 31.94B | |||||
Total Assets | 8.54B | 23.67B | 30.5B | 259B | 313B | |||||
Interest Expense | -98.37M | -133M | -139M | -124M | -145M | |||||
Income Tax Expense | -129M | 86.97M | 594M | -1.07B | -923M | |||||
D&A | 15.76M | 18.83M | 27.33M | 594M | 803M | |||||
CAPEX | -39.5M | -59.56M | -64.74M | - | - | |||||
Net Income | 843M | 157M | 1.84B | -3.21B | 5.05B | |||||
EBT | 1.41B | 554M | 4.86B | -5.82B | 5.59B |
- Stock Market
- Equities
- APO Stock
- Financials Apollo Global Management, Inc.
- Business Segments